Novacyt Sa Stock Market Value

NVYTF Stock  USD 0.70  0.13  22.81%   
Novacyt SA's market value is the price at which a share of Novacyt SA trades on a public exchange. It measures the collective expectations of Novacyt SA investors about its performance. Novacyt SA is trading at 0.7 as of the 18th of December 2024. This is a 22.81% up since the beginning of the trading day. The stock's lowest day price was 0.7.
With this module, you can estimate the performance of a buy and hold strategy of Novacyt SA and determine expected loss or profit from investing in Novacyt SA over a given investment horizon. Check out Novacyt SA Correlation, Novacyt SA Volatility and Novacyt SA Alpha and Beta module to complement your research on Novacyt SA.
Symbol

Please note, there is a significant difference between Novacyt SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novacyt SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novacyt SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Novacyt SA 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novacyt SA's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novacyt SA.
0.00
10/19/2024
No Change 0.00  0.0 
In 2 months and 2 days
12/18/2024
0.00
If you would invest  0.00  in Novacyt SA on October 19, 2024 and sell it all today you would earn a total of 0.00 from holding Novacyt SA or generate 0.0% return on investment in Novacyt SA over 60 days. Novacyt SA is related to or competes with Aethlon Medical, Bone Biologics, Tivic Health, Cytosorbents Crp, Inspira Technologies, Brainsway, and Rapid Micro. Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercializ... More

Novacyt SA Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novacyt SA's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novacyt SA upside and downside potential and time the market with a certain degree of confidence.

Novacyt SA Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Novacyt SA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novacyt SA's standard deviation. In reality, there are many statistical measures that can use Novacyt SA historical prices to predict the future Novacyt SA's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novacyt SA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.705.21
Details
Intrinsic
Valuation
LowRealHigh
0.030.625.13
Details
Naive
Forecast
LowNextHigh
0.020.835.34
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.700.700.70
Details

Novacyt SA Backtested Returns

Novacyt SA has Sharpe Ratio of -0.0863, which conveys that the firm had a -0.0863% return per unit of risk over the last 3 months. Novacyt SA exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novacyt SA's Risk Adjusted Performance of (0.05), standard deviation of 4.44, and Mean Deviation of 1.4 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.37, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Novacyt SA are expected to decrease at a much lower rate. During the bear market, Novacyt SA is likely to outperform the market. At this point, Novacyt SA has a negative expected return of -0.39%. Please make sure to verify Novacyt SA's value at risk and day median price , to decide if Novacyt SA performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.4  

Poor reverse predictability

Novacyt SA has poor reverse predictability. Overlapping area represents the amount of predictability between Novacyt SA time series from 19th of October 2024 to 18th of November 2024 and 18th of November 2024 to 18th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novacyt SA price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Novacyt SA price fluctuation can be explain by its past prices.
Correlation Coefficient-0.4
Spearman Rank Test0.64
Residual Average0.0
Price Variance0.0

Novacyt SA lagged returns against current returns

Autocorrelation, which is Novacyt SA pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Novacyt SA's pink sheet expected returns. We can calculate the autocorrelation of Novacyt SA returns to help us make a trade decision. For example, suppose you find that Novacyt SA has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Novacyt SA regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Novacyt SA pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Novacyt SA pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Novacyt SA pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Novacyt SA Lagged Returns

When evaluating Novacyt SA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Novacyt SA pink sheet have on its future price. Novacyt SA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Novacyt SA autocorrelation shows the relationship between Novacyt SA pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Novacyt SA.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Novacyt Pink Sheet

Novacyt SA financial ratios help investors to determine whether Novacyt Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novacyt with respect to the benefits of owning Novacyt SA security.